Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 9, 2007

View Archived Issues

SASP technology: a novel approach to treat bacterial infections

MenACWY-TT meningococcal vaccine immunogenic in children

In vitro studies reveal antibacterial activity of novel carbapenem ME-1036

Sitafloxacin demonstrates efficacy against urinary tract infection pathogens

New antidiabetic agents disclosed in recent patents

Novel antiinfective agents disclosed in recent patent literature

Prexige withdrawn from Canadian market

Lilly advances atomoxetine to phase II for adult ADHD in Japan

Aptivus receives full FDA approval as part of combination therapy for HIV

Genesis to continue to use MorphoSys' HuCAL-based antibodies for drug discovery

GSK seeks prequalification for Cervarix from the WHO

Interim analysis complete in pivotal pafuramidine trial for African sleeping sickness

Phase I study commences for topical diclofenac sodium patch

Top-line results reported for granulated mesalamine in ulcerative colitis

TopoTarget and Lundbeck sign agreement for siramesine

Wyeth acquires biopharmaceutical company Haptogen

Ixabepilone improves progression-free survival in phase III metastatic breast cancer study

HI-164 vaccine reduces hospitalizations in COPD patients

Ki-26894 shows potential for the treatment of gastric cancer in vivo

EpiCept successfully completes phase I with novel small-molecule VDA

Avontec advances AVT-02 UE into the clinic for inflammatory skin diseases

Positive phase IIb data reported for BHT-3009 in multiple sclerosis

Loss of T-bet function leads to a communicable form of ulcerative colitis in mice / News in Context

Positive interim data reported for PRX-302

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...